Stage shift in PSA-detected prostate cancers - effect modification by Gleason score. - Wikidata - wikimedia - TriplyDB

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

http://www.wikidata.org/entity/Q37248410

about

Historical prostate cancer screening and treatment outcomes from a single institution The Treatment of Localized Prostate Cancer in Everyday Practice in Germany Gleason grade progression is uncommon.Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screening.PSA-detected prostate cancer and the potential for dedifferentiation--estimating the proportion capable of progression.Stage of cancer diagnoses among migrants from the former Soviet Union in comparison to the German population - are diagnoses among migrants delayed?Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?

P2860

Q36170995-2F36FE35-1B35-4FC3-8F63-EC953E5E9FF3 Q36996753-405708BD-AA44-45DF-8A3E-FBB31CBBBAE1 Q37177744-48761D59-B5D4-4AED-8FAC-9948FB1AD198 Q43814269-E5E73DD7-01F8-4DF6-8C7C-0AB50D90BC9F Q46826597-6ED71DCA-3BC6-4FDB-A089-5420B6B04D86 Q47552208-60BE7A3A-9B87-4C33-BE6D-B89BA7BE9571 Q48214876-8FC25819-2AF8-48A5-B77F-E219FB7F8614

P2860

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

http://www.wikidata.org/entity/Q37248410

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@en

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@nl

type

label

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@en

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@nl

prefLabel

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@en

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@nl

P1433

Q37248410-58775559-486F-440E-8CFE-F7BC01172B9A

P1476

Q37248410-B14F64B7-8B8F-476E-9D4D-B071DE1828C8

P2093

Q37248410-87EBEB63-5C3E-4692-A4B0-A44BB81B809B

Q37248410-AF0A9D38-0CFC-4A7D-B35F-EFC07DCBBD0C

Q37248410-F57F2244-656F-4E51-A18C-072647DA1F91

Q37248410-FAA82D62-8F7A-4C40-9F17-002186FD37F8

P2860

Q37248410-0638D753-6ADD-4A8D-B468-2F24BFF153DD

Q37248410-1BD91370-527D-49FA-9FBD-FF40E1331198

Q37248410-6F723BAB-F265-4277-B68D-448C39845FE3

Q37248410-7CE6E4AA-12C8-4FEA-B341-AB1D93D88AC4

Q37248410-ACEAE06E-AAC7-4188-B895-15AEC75F6330

Q37248410-C2F65656-C63F-463B-BE85-984165EBF0AF

Q37248410-C855B32E-0088-4772-839B-0BEEE3623C6A

Q37248410-FCBAC90C-771D-4F83-A551-0B554CBFCEED

P304

Q37248410-9D832B41-FDA3-4AA4-AD2B-2001E51C7D83

P31

Q37248410-76A28A98-BCA7-430D-942A-E5D626D6CDBE

P356

Q37248410-3379B98E-2C8E-4B56-952A-55EAB0D9754B

P433

Q37248410-38E82882-343A-4C52-AB5B-055EB5BDD7D0

P478

Q37248410-BF6230B8-2352-4A84-BCE2-3F2AA823FA68

P50

Q37248410-350A7DDF-0818-4A3C-9A97-4073AD235763

Q37248410-A4BE79C0-2E65-43C0-B452-9822F373868A

Q37248410-B7FB599A-6694-4CD2-A40C-18A2951688C7

Q37248410-EEA8884D-FA6C-4BA9-B406-6DDFD47FA63E

P577

Q37248410-011C0200-206E-4D65-8942-A2A0C28A4522

P5875

Q37248410-90B09B83-1C73-4141-B9F1-1399052F96A0

P698

Q37248410-05D5AD69-6AC1-4FA9-B02F-E7804280ACA4

P932

Q37248410-BBE56282-98E4-41B1-B448-8259176DA3DD

P356

JMS.2009.009037

P1433

Journal of Medical Screening

P1476

Stage shift in PSA-detected prostate cancers - effect modification by Gleason score.

@en

P2093

David Greenberg

http://www.w3.org/2001/XMLSchema#string

Freddie Hamdy

http://www.w3.org/2001/XMLSchema#string

Jenny Donovan

http://www.w3.org/2001/XMLSchema#string

Stephen W Duffy

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Screening and prostate-cancer mortality in a randomized European study

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

Quantifying the role of PSA screening in the US prostate cancer mortality decline.

Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening.

Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study.

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

P304

98-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/JMS.2009.009037

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Richard M Martin

Paul D P Pharoah

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26328542

http://www.w3.org/2001/XMLSchema#string

P698

19564523

http://www.w3.org/2001/XMLSchema#string

P932

2704964

http://www.w3.org/2001/XMLSchema#string